Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
81.66
Oct 22 • 3:59 PM ET Dollar change+2.98 Percentage change(3.79%)
Aftermarket Close
81.66
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Oct 20, 8:32 PMHealthcare rotation lifts Globus Medical 4.4% as the sector reaches a record high
Index
-
Market Cap
10.96B
Enterprise Value
10.48B
Income
535.43M
Sales
3.14B
Book/sh
35.52
Cash/sh
4.43
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
6000
IPO
Aug 03, 2012
P/E
20.88
Forward P/E
15.14
PEG
1.10
P/S
3.49
P/B
2.30
P/C
18.42
P/FCF
14.51
EV/EBITDA
10.94
EV/Sales
3.33
Quick Ratio
2.93
Current Ratio
4.62
Debt/Eq
0.02
LT Debt/Eq
0.02
Option/Short
Yes / Yes
EPS (ttm)
3.91
EPS next Y
5.39
EPS next Q
1.20
EPS this Y
25.64%
EPS next Y
7.83%
EPS next 5Y
13.83%
EPS past 3/5Y
28.43% 31.11%
Sales past 3/5Y
42.17% 30.08%
EPS Y/Y TTM
51.10%
Sales Y/Y TTM
19.74%
EPS Q/Q
-25.77%
Sales Q/Q
5.94%
Insider Own
17.32%
Insider Trans
-0.34%
Inst Own
89.54%
Inst Trans
7.14%
ROA
10.25%
ROE
11.81%
ROIC
11.00%
Gross Margin
64.90%
Oper. Margin
21.53%
Profit Margin
17.03%
SMA20
7.17%
SMA50
4.37%
SMA200
-2.59%
Trades
Shs Outstand
111.82M
Shs Float
111.00M
52W High
101.40 -19.47%
52W Low
59.51 37.22%
Volatility
3.41% 2.61%
ATR (14)
2.21
RSI (14)
64.01
Beta
0.99
Rel Volume
0.90
Avg Volume
1.43M
Volume
1,294,065
Perf Week
3.58%
Perf Month
10.41%
Perf Quarter
6.76%
Perf Half Y
-13.48%
Perf YTD
-6.47%
Perf Year
30.97%
Perf 3Y
59.15%
Perf 5Y
2.18%
Perf 10Y
253.66%
Prev Close
78.68
Price
81.66
Change %
3.79%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TOBIN JAMES RDirectorSep 15 '26Option Exercise58.7230,0001,761,45030,000Sep 16 04:35 PM
TOBIN JAMES RDirectorSep 15 '26Sale74.5830,0002,237,5020Sep 16 04:35 PM
TOBIN JAMES RDirectorSep 15 '26Proposed Sale74.5330,0002,236,000Sep 15 02:28 PM
ZARRILLI STEPHEN TDirectorAug 18 '26Option Exercise53.2725,0001,331,75025,000Aug 19 05:07 PM
ZARRILLI STEPHEN TDirectorAug 18 '26Sale87.0425,0002,175,9650Aug 19 05:07 PM
ZARRILLI STEPHEN TDirectorAug 18 '26Proposed Sale87.0425,0002,176,000Aug 18 04:23 PM
Davidar David DDirectorJun 05 '26Option Exercise26.2725,000656,750535,175Jun 09 05:04 PM
Davidar David DDirectorJun 05 '26Sale80.7625,0002,019,072510,175Jun 09 05:04 PM
RHOADS ANN DDirectorJun 04 '26Option Exercise26.2725,000656,75040,384Jun 08 05:14 PM
Davidar David DDirectorJun 05 '26Proposed Sale81.0025,0002,025,000Jun 05 03:15 PM
DeFord John AFormer DirectorApr 14 '26Proposed Sale93.1030,0002,793,128Apr 14 03:34 PM
Huller KellyEVP, GC, Corporate SecretaryFeb 25 '26Option Exercise43.5820,000871,60020,000Feb 27 05:53 PM
Huller KellyEVP, GC, Corporate SecretaryFeb 25 '26Sale94.5020,0001,890,0000Feb 27 05:53 PM
Huller KellyOfficerFeb 25 '26Proposed Sale94.4520,0001,889,000Feb 25 03:41 PM
Huller KellyEVP, GC, Corporate SecretaryFeb 12 '26Option Exercise45.6410,000456,40010,000Feb 17 05:22 PM
Huller KellyEVP, GC, Corporate SecretaryFeb 12 '26Sale87.6710,000876,7000Feb 17 05:22 PM
Huller KellyOfficerFeb 12 '26Proposed Sale87.6010,000876,000Feb 12 12:12 PM
Kline KyleSenior Vice President, CFOJan 08 '26Option Exercise51.873,594186,4213,594Jan 12 05:40 PM
Kline KyleSenior Vice President, CFOJan 08 '26Sale101.103,594363,3530Jan 12 05:40 PM
Norwalk Leslie VDirectorJan 08 '26Sale101.102,000202,20010,419Jan 12 05:36 PM
Kline KyleOfficerJan 08 '26Proposed Sale101.053,594363,167Jan 08 01:52 PM
Norwalk Leslie VDirectorJan 08 '26Proposed Sale101.002,000202,000Jan 08 01:10 PM
Norwalk Leslie VDirectorDec 12 '25Sale88.854,000355,40012,419Dec 16 04:18 PM
Norwalk Leslie VDirectorDec 12 '25Proposed Sale88.754,000355,000Dec 12 04:00 PM
Paul David CExecutive ChairmanDec 08 '25Option Exercise25.5234,375877,25060,417Dec 10 04:37 PM
Kline KyleSenior Vice President, CFODec 01 '25Option Exercise59.8618,5421,109,87618,542Dec 03 08:23 PM
Kline KyleSenior Vice President, CFODec 01 '25Sale90.0018,5421,668,7800Dec 03 08:23 PM
Kline KyleOfficerDec 01 '25Proposed Sale89.9518,5421,667,847Dec 01 03:59 PM
Huller KellySVP, GC, Corporate SecretaryNov 25 '25Option Exercise25.967,500194,7007,500Nov 28 05:31 PM
Huller KellySVP, GC, Corporate SecretaryNov 25 '25Sale90.007,500675,0000Nov 28 05:31 PM
Huller KellyOfficerNov 25 '25Proposed Sale90.007,500675,000Nov 25 11:07 AM
Davidar David DDirectorNov 12 '25Option Exercise25.5225,000638,000541,275Nov 13 05:12 PM
Davidar David DDirectorNov 12 '25Sale86.0025,0002,150,005516,275Nov 13 05:12 PM
ZARRILLI STEPHEN TDirectorNov 11 '25Option Exercise44.1425,0001,103,50025,000Nov 13 05:06 PM
ZARRILLI STEPHEN TDirectorNov 11 '25Sale84.2925,0002,107,2580Nov 13 05:06 PM
Davidar David DDirectorNov 12 '25Proposed Sale85.9525,0002,148,750Nov 12 12:35 PM
ZARRILLI STEPHEN TDirectorNov 11 '25Proposed Sale84.2425,0002,106,000Nov 12 08:45 AM
RHOADS ANN DDirectorNov 10 '25Proposed Sale85.002,000170,000Nov 10 04:55 PM
RHOADS ANN DDirectorNov 07 '25Sale81.008,000648,00017,384Nov 10 04:15 PM
RHOADS ANN DDirectorNov 10 '25Sale85.002,000170,00015,384Nov 10 04:15 PM
RHOADS ANN DDirectorNov 07 '25Proposed Sale80.968,000647,681Nov 07 12:17 PM
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. The firm classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in 2003 and is headquartered in Audubon, PA.
Co-Founder & Executive ChairmanMr. David C. Paul
CEOMr. Keith W. Pfeil
Senior VP & CFOMr. Kyle R. Klin
Executive VPMs. Kelly G. Huller Esq.
Senior Vice President of Business Development & Investor RelationsMr. Brian J. Kearns